DrugPatentWatch Database Preview
Watson Labs Company Profile
What is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?
WATSON LABS has one thousand and forty-one approved drugs.
There are twenty-three tentative approvals on WATSON LABS drugs.
Summary for Watson Labs
| US Patents: | 0 |
| Tradenames: | 401 |
| Ingredients: | 378 |
| NDAs: | 1041 |
Drugs and US Patents for Watson Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 088345-001 | Jul 28, 1983 | DISCN | No | No | See Pricing | See Pricing | |||||
| Watson Labs | PINDOLOL | pindolol | TABLET;ORAL | 074437-002 | Feb 27, 1995 | DISCN | No | No | See Pricing | See Pricing | |||||
| Watson Labs | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074228-001 | Oct 15, 1996 | DISCN | No | No | See Pricing | See Pricing | |||||
| Watson Labs | PREDNISONE | prednisone | TABLET;ORAL | 085161-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
